Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Free Subscription


1 Antiviral Res
1 Arch Virol
1 Biochem Biophys Res Commun
1 J Immunol
2 J Infect
3 J Infect Dis
4 J Virol
3 Lancet
1 Lancet Glob Health
1 Lancet Infect Dis
8 Lancet Oncol
1 Lancet Planet Health
1 Lancet Public Health
3 Lancet Respir Med
12 N Engl J Med
2 Pediatrics
1 PLoS Comput Biol
2 PLoS One
8 Proc Natl Acad Sci U S A
5 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Antiviral Res

  1. TILMANIS D, Koszalka P, Barr IG, Rossignol JF, et al
    Host-targeted Nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.
    Antiviral Res. 2020 Jun 13:104851. doi: 10.1016/j.antiviral.2020.104851.
    PubMed         Abstract available

    Arch Virol

  2. DA COSTA VG, Moreli ML, Saivish MV
    The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century.
    Arch Virol. 2020;165:1517-1526.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  3. BONGINI P, Trezza A, Bianchini M, Spiga O, et al
    A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization.
    Biochem Biophys Res Commun. 2020;528:35-38.
    PubMed         Abstract available


    Covid-19: Lack of confidentiality affects healthcare staff too.
    BMJ. 2020;369:m2293.

  5. MELNICK ER, Ioannidis JPA
    Should governments continue lockdown to slow the spread of covid-19?
    BMJ. 2020;369:m1924.

  6. TOUBIANA J, Poirault C, Corsia A, Bajolle F, et al
    Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.
    BMJ. 2020;369:m2094.
    PubMed         Abstract available

    Chief coroner's guidance on covid-19 deaths: workers outside the NHS are also vulnerable to risk.
    BMJ. 2020;369:m2179.

  8. BRADLEY SH, Kirby E, Wheatstone P
    Managing individual and population risk from covid-19.
    BMJ. 2020;369:m2098.

    J Immunol

  9. CASALINO-MATSUDA SM, Chen F, Gonzalez-Gonzalez FJ, Nair A, et al
    Hypercapnia Suppresses Macrophage Antiviral Activity and Increases Mortality of Influenza A Infection via Akt1.
    J Immunol. 2020 Jun 15. pii: jimmunol.2000085. doi: 10.4049/jimmunol.2000085.
    PubMed         Abstract available

    J Infect

  10. PINANA JL, Gimenez E, Gomez MD, Perez A, et al
    Pulmonary Cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: implications for the diagnosis of CMV pneumonia.
    J Infect. 2019 Feb 21. pii: S0163-4453(19)30058.
    PubMed         Abstract available

  11. GREEN CA, Sande CJ, Scarselli E, Capone S, et al
    Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
    J Infect. 2019 Feb 8. pii: S0163-4453(19)30038.
    PubMed         Abstract available

    J Infect Dis

  12. ALLEN J
    My Future in Medicine: How COVID-19 Is Inspiring the Next Generation of Infectious Disease Specialists.
    J Infect Dis. 2020;221:1938-1939.

  13. PAN Y, Yu X, Du X, Li Q, et al
    Epidemiological and Clinical Characteristics of 26 Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Carriers.
    J Infect Dis. 2020;221:1940-1947.
    PubMed         Abstract available

  14. JIANG XL, Zhang XL, Zhao XN, Li CB, et al
    Transmission Potential of Asymptomatic and Paucisymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections: A 3-Family Cluster Study in China.
    J Infect Dis. 2020;221:1948-1952.
    PubMed         Abstract available

    J Virol

  15. XU C, Xu B, Wu Y, Yang S, et al
    Erratum for Xu et al., "A Single Amino Acid at Position 431 of the PB2 Protein Determines the Virulence of H1N1 Swine Influenza Viruses in Mice".
    J Virol. 2020;94.

  16. BLANCO JCG, Fernando LR, Zhang W, Kamali A, et al
    Alternative Virus-Like Particle-Associated Pre-Fusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
    J Virol. 2019 Sep 11. pii: JVI.00914-19. doi: 10.1128/JVI.00914.
    PubMed         Abstract available

  17. CAGLIANI R, Forni D, Clerici M, Sironi M, et al
    Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2.
    J Virol. 2020 Apr 1. pii: JVI.00411-20. doi: 10.1128/JVI.00411.
    PubMed         Abstract available

  18. WANG M, Li M, Ren R, Li L, et al
    International expansion of a novel SARS-CoV-2 mutant.
    J Virol. 2020 Apr 8. pii: JVI.00567-20. doi: 10.1128/JVI.00567.
    PubMed         Abstract available


  19. ABBASI J
    Existing Drugs Might Treat COVID-19.
    JAMA. 2020;323:2239.

  20. CUTLER D
    How Will COVID-19 Affect the Health Care Economy?
    JAMA. 2020;323:2237-2238.


  21. ZHU FC, Li YH, Guan XH, Hou LH, et al
    Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
    Lancet. 2020 May 22. pii: S0140-6736(20)31208.
    PubMed         Abstract available

  22. KRIEGER N, Chen JT, Waterman PD
    Excess mortality in men and women in Massachusetts during the COVID-19 pandemic.
    Lancet. 2020 May 27. pii: S0140-6736(20)31234.

  23. USHER AD
    COVID-19 vaccines for all?
    Lancet. 2020;395:1822-1823.

    Lancet Glob Health

  24. BASSAT Q, Watkins K, Peterson S, Bijleveld P, et al
    The first Global Pneumonia Forum: recommendations in the time of coronavirus.
    Lancet Glob Health. 2020;8:e762-e763.

    Lancet Infect Dis

  25. RUAN S
    Likelihood of survival of coronavirus disease 2019.
    Lancet Infect Dis. 2020;20:630-631.

    Lancet Oncol

  26. MAURI D, Kamposioras K, Tolia M, Alongi F, et al
    Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic.
    Lancet Oncol. 2020 May 13. pii: S1470-2045(20)30278.

  27. FOSKER C
    COVID-19 and cancer care in Bermuda.
    Lancet Oncol. 2020;21:761-762.

  28. PRICE P, Barney SE
    Initiation of the Global Coalition for Radiotherapy during the COVID-19 pandemic.
    Lancet Oncol. 2020;21:752-753.

    COVID-19 and the US health insurance conundrum.
    Lancet Oncol. 2020;21:733.

  30. BURKI TK
    COVID-19: consequences for higher education.
    Lancet Oncol. 2020 May 21. pii: S1470-2045(20)30287.

  31. VASQUEZ L, Sampor C, Villanueva G, Maradiegue E, et al
    Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America.
    Lancet Oncol. 2020 May 18. pii: S1470-2045(20)30280.

  32. JONES D, Neal RD, Duffy SRG, Scott SE, et al
    Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care.
    Lancet Oncol. 2020 Apr 30. pii: S1470-2045(20)30242.

  33. DINMOHAMED AG, Visser O, Verhoeven RHA, Louwman MWJ, et al
    Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands.
    Lancet Oncol. 2020 Apr 30. pii: S1470-2045(20)30265.

    Lancet Planet Health

  34. HERRERO M, Thornton P
    What can COVID-19 teach us about responding to climate change?
    Lancet Planet Health. 2020;4:e174.

    Lancet Public Health

  35. FADEL M, Salomon J, Descatha A
    Coronavirus outbreak: the role of companies in preparedness and responses.
    Lancet Public Health. 2020;5:e193.

    Lancet Respir Med

  36. HAMMER MM, Raptis CA, Henry TS, Shah A, et al
    Challenges in the interpretation and application of typical imaging features of COVID-19.
    Lancet Respir Med. 2020 May 18. pii: S2213-2600(20)30233.

  37. HOWITT R, de Jesus GA, Araujo F, Francis J, et al
    Screening and triage at health-care facilities in Timor-Leste during the COVID-19 pandemic.
    Lancet Respir Med. 2020 Apr 22. pii: S2213-2600(20)30183.

  38. MCENERY T, Gough C, Costello RW
    COVID-19: Respiratory support outside the intensive care unit.
    Lancet Respir Med. 2020 Apr 9. pii: S2213-2600(20)30176.

    N Engl J Med

  39. ROME BN, Avorn J
    Drug Evaluation during the Covid-19 Pandemic.
    N Engl J Med. 2020 Apr 14. doi: 10.1056/NEJMp2009457.

  40. WAKAM GK, Montgomery JR, Biesterveld BE, Brown CS, et al
    Not Dying Alone - Modern Compassionate Care in the Covid-19 Pandemic.
    N Engl J Med. 2020 Apr 14. doi: 10.1056/NEJMp2007781.

  41. GUDBJARTSSON DF, Helgason A, Jonsson H, Magnusson OT, et al
    Spread of SARS-CoV-2 in the Icelandic Population.
    N Engl J Med. 2020 Apr 14. doi: 10.1056/NEJMoa2006100.
    PubMed         Abstract available

  42. GREIN J, Ohmagari N, Shin D, Diaz G, et al
    Compassionate Use of Remdesivir for Patients with Severe Covid-19.
    N Engl J Med. 2020 Apr 10. doi: 10.1056/NEJMoa2007016.
    PubMed         Abstract available

  43. LEWIS MA
    Between Scylla and Charybdis - Oncologic Decision Making in the Time of Covid-19.
    N Engl J Med. 2020 Apr 7. doi: 10.1056/NEJMp2006588.

    The Untold Toll - The Pandemic's Effects on Patients without Covid-19.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMms2009984.

  45. GOYAL P, Choi JJ, Pinheiro LC, Schenck EJ, et al
    Clinical Characteristics of Covid-19 in New York City.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2010419.

  46. LUBEL J, Garg M
    Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    N Engl J Med. 2020;382.

  47. HAUG G, Eapen MS, Sohal SS
    Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    N Engl J Med. 2020;382.

    Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    N Engl J Med. 2020;382.

  49. VADUGANATHAN M, Solomon SD
    Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. Reply.
    N Engl J Med. 2020;382.

  50. RUBIN EJ, Baden LR, Evans M, Morrissey S, et al
    Audio Interview: The Impact of Covid-19 on Minority Communities.
    N Engl J Med. 2020;382:e111.


  51. KEMPE A, Saville AW, Albertin C, Zimet G, et al
    Parental Hesitancy About Routine Childhood and Influenza Vaccinations: A National Survey.
    Pediatrics. 2020 Jun 15. pii: peds.2019-3852. doi: 10.1542/peds.2019-3852.
    PubMed         Abstract available

  52. DONG Y, Mo X, Hu Y, Qi X, et al
    Epidemiology of COVID-19 Among Children in China.
    Pediatrics. 2020;145.
    PubMed         Abstract available

    PLoS Comput Biol

  53. YANG W, Lau EHY, Cowling BJ
    Dynamic interactions of influenza viruses in Hong Kong during 1998-2018.
    PLoS Comput Biol. 2020;16:e1007989.
    PubMed         Abstract available

    PLoS One

  54. YIN F, Xia X, Song N, Zhu L, et al
    Quantify the role of superspreaders -opinion leaders- on COVID-19 information propagation in the Chinese Sina-microblog.
    PLoS One. 2020;15:e0234023.
    PubMed         Abstract available

  55. MUTO K, Yamamoto I, Nagasu M, Tanaka M, et al
    Japanese citizens' behavioral changes and preparedness against COVID-19: An online survey during the early phase of the pandemic.
    PLoS One. 2020;15:e0234292.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  56. RAKER EJ, Zacher M, Lowe SR
    Lessons from Hurricane Katrina for predicting the indirect health consequences of the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:12595-12597.
    PubMed         Abstract available

  57. SANCHEZ-PACHECO SJ, Kong S, Pulido-Santacruz P, Murphy RW, et al
    Median-joining network analysis of SARS-CoV-2 genomes is neither phylogenetic nor evolutionary.
    Proc Natl Acad Sci U S A. 2020;117:12518-12519.

  58. MAVIAN C, Pond SK, Marini S, Magalis BR, et al
    Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable.
    Proc Natl Acad Sci U S A. 2020;117:12522-12523.

  59. FORSTER P, Forster L, Renfrew C, Forster M, et al
    Reply to Sanchez-Pacheco et al., Chookajorn, and Mavian et al.: Explaining phylogenetic network analysis of SARS-CoV-2 genomes.
    Proc Natl Acad Sci U S A. 2020;117:12524-12525.

    Evolving COVID-19 conundrum and its impact.
    Proc Natl Acad Sci U S A. 2020;117:12520-12521.

  61. ZENG F, Chen X, Deng G
    Convalescent plasma for patients with COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:12528.

  62. KESICI S, Yavuz S, Bayrakci B
    Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:12526-12527.

  63. DUAN K, Liu B, Li C, Zhang H, et al
    Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:12529-12530.


    A Veterinary Vaccine Development Process Map to assist in the development of new vaccines.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30613.
    PubMed         Abstract available

  65. CHOI EJ, Park JH, Chun BC
    Cost effectiveness of trivalent and quadrivalent influenza vaccines in 50- to 64-year-old adults in Korea.
    Vaccine. 2020 Jun 9. pii: S0264-410X(20)30710.
    PubMed         Abstract available

  66. AIDOUD A, Marlet J, Angoulvant D, Debacq C, et al
    Influenza vaccination as a novel means of preventing coronary heart disease: Effectiveness in older adults.
    Vaccine. 2020 Jun 11. pii: S0264-410X(20)30725.
    PubMed         Abstract available

  67. KELLY MK, Grundmeier RW, Stephens-Shields AJ, Localio R, et al
    Missed opportunities for human papillomavirus vaccination at office visits during which influenza vaccine was administered: An AAP pediatric research in office settings (PROS) national primary care research network study.
    Vaccine. 2020 Jun 12. pii: S0264-410X(20)30757.
    PubMed         Abstract available

  68. COOKENHAM T, Lanzer KG, Gage E, Lorenzo EC, et al
    Vaccination of aged mice with adjuvanted recombinant influenza nucleoprotein enhances protective immunity.
    Vaccine. 2020 Jun 12. pii: S0264-410X(20)30752.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.